Inventor
SCHEID JOHANNES
US13 patents
⚠️ This page may combine multiple inventors who share the name “SCHEID JOHANNES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV ROCKEFELLER
6 patentsUS12071470B2Aug 27, 2024
Human immunodeficiency virus neutralizing antibodies and methods of use thereof
UNIV ROCKEFELLER2 citations72
US12428472B2Sep 30, 2025
Human immunodeficiency virus neutralizing antibodies and methods of use thereof
UNIV ROCKEFELLER0 citations62
US11634478B2Apr 25, 2023
Human immunodeficiency virus neutralizing antibodies and methods of use thereof
UNIV ROCKEFELLER0 citations62
US10889633B2Jan 12, 2021
Human immunodeficiency virus neutralizing antibodies and methods of use thereof
UNIV ROCKEFELLER0 citations62
US11155605B2Oct 26, 2021
Nucleic acids encoding broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 ENV subunits
UNIV ROCKEFELLER0 citations61
US10421803B2Sep 24, 2019
Broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 Env subunits
UNIV ROCKEFELLER0 citations51
CALIFORNIA INST OF TECHN
4 patentsUS9493549B2Nov 15, 2016
Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
CALIFORNIA INST OF TECHN55 citations97
US10590187B2Mar 17, 2020
Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120
CALIFORNIA INST OF TECHN1 citations71
US12054538B2Aug 6, 2024
Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120
CALIFORNIA INST OF TECHN0 citations62
US11472868B2Oct 18, 2022
Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120
CALIFORNIA INST OF TECHN0 citations61